Lydia E. Makaroff

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.

Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: September 04, 2026

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

Journal: European urology oncology

Published: December 18, 2025

Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.

Journal: European urology oncology

Published: October 30, 2025

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.

ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.

Journal: The New England journal of medicine

Published: October 22, 2025

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 11, 2025

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update.

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: Summary of the 2025 Update.

Journal: European urology

Published: February 17, 2025

Patient experience of surveillance following radical treatment for muscle-invasive bladder cancer.

Patient experience of surveillance following radical treatment for muscle-invasive bladder cancer.

Journal: BJU international

Published: December 14, 2023

Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.

Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression in Non-muscle-invasive Bladder Cancer.

Journal: European urology oncology

Published: October 22, 2023

Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus Process.

Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus Process.

Journal: JCO global oncology

Published: August 10, 2023

Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare.

Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 03, 2023

Strategic career building during your PhD: a timeline for maximizing your opportunities.

Strategic career building during your PhD: a timeline for maximizing your opportunities.

Journal: Immunology and cell biology

Published: June 12, 2023

A major conditions strategy cannot replace a national cancer plan-patient advocates voice their concerns.

A major conditions strategy cannot replace a national cancer plan-patient advocates voice their concerns.

Journal: The Lancet. Oncology

Published: March 21, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026